Healthcare stocks
247 listed companies in the Healthcare sector.
| Company | Price | Change | Market cap | P/E | Dividend |
|---|---|---|---|---|---|
| Eli Lilly andLLY | $1,443.50 | +1.14% | $1.29T | 46.9 | 0.5% |
| Johnson & JohnsonJNJ | $285.75 | +0.79% | $687.89B | 43.4 | 1.8% |
| AbbVieABBV | $295.03 | +0.20% | $521.5B | 50.6 | 2.3% |
| Roche HoldingROP | CHF 407.60 | +0.72% | CHF 322.45B | 26.4 | 2.4% |
| UnitedHealth GroupUNH | $407.46 | +0.58% | $365.09B | 23.3 | 2.2% |
| MerckMRK · NYSE | $147.76 | +0.55% | $364.26B | 147.8 | 2.3% |
| NovartisNOVN · SIX | CHF 135.64 | +1.18% | CHF 253.19B | 32.1 | 2.7% |
| AstraZenecaAZN · LSE | 14,030.00 GBp | +0.34% | £216.85B | 26.5 | 1.7% |
| Thermo Fisher ScientificTMO | $700.22 | +0.11% | $259.44B | 36.9 | 0.3% |
| AmgenAMGN | $465.67 | −0.30% | $251.89B | 27.0 | 2.1% |
| Gilead SciencesGILD | $168.08 | +0.08% | $208.48B | — | 1.9% |
| Abbott LaboratoriesABT | $108.52 | +1.18% | $187.95B | 40.5 | 2.3% |
| Novo NordiskNOVO.B · Nasdaq Copenhagen | kr 287.70 | +3.32% | kr 1.23T | 10.9 | 4.1% |
| PfizerPFE | $28.89 | +0.21% | $164.67B | 41.3 | 6.0% |
| DanaherDHR | $233.02 | +0.37% | $163.94B | 38.6 | 0.7% |
| Intuitive SurgicalISRG | $443.59 | +0.84% | $153.77B | 53.6 | — |
| Vertex PharmaceuticalsVRTX | $538.60 | −0.74% | $136.56B | 34.7 | — |
| MedtronicMDT | $102.86 | +1.85% | $131.57B | 25.3 | 2.8% |
| Bristol-Myers SquibbBMY | $63.43 | +1.78% | $129.66B | 14.1 | 4.0% |
| McKessonMCK | $1,102.81 | +2.39% | $127.33B | 28.4 | 0.3% |
| StrykerSYK | $309.64 | −0.88% | $117.88B | 33.0 | 1.1% |
| SanofiSAN · Euronext Paris | €87.80 | +0.23% | €105.17B | 25.3 | 4.7% |
| CVS HealthCVS | $89.35 | −0.49% | $114.32B | 10.4 | 3.0% |
| HCA HealthcareHCA | $499.05 | −0.32% | $104.25B | 16.6 | 0.6% |
| GSKGSK · LSE | 1,929.00 GBp | +0.92% | £76.63B | 17.9 | 3.6% |
| Regeneron PharmaceuticalsREGN | $955.47 | +0.45% | $98.84B | 21.1 | 0.4% |
| EssilorLuxotticaEL | €184.80 | +1.34% | €83.58B | 34.1 | 2.2% |
| ModernaMRNA | $223.37 | −3.45% | $90.38B | — | — |
| CencoraCOR | $359.03 | +2.76% | $68.51B | 20.0 | 0.7% |
| WuXi AppTec603259 | ¥144.41 | −1.29% | ¥444.01B | 16.3 | 0.4% |
| CSLCSL | $202.52 | −0.20% | $96.75B | — | 2.0% |
| Boston ScientificBSX | $44.34 | +0.32% | $64.27B | 18.7 | — |
| UCBUCB | €295.70 | −0.27% | €56.53B | 26.2 | 0.5% |
| Edwards LifesciencesEW | $107.15 | +1.28% | $61.61B | 61.6 | — |
| BayerBAYN | €57.04 | +0.92% | €55.53B | — | 0.2% |
| argenxARGX · NASDAQ | $960.04 | −2.17% | $60.37B | 33.3 | — |
About the Healthcare sector
The health care sector includes pharmaceutical and biotechnology companies, makers of medical devices and diagnostics, and providers of health services and insurance.
Drug makers depend on research pipelines, clinical trial results and patent expiries; device makers on innovation and hospital spending; service providers on regulation and reimbursement rules. Demand for health care is relatively stable through economic cycles, which is why the sector is often considered defensive.
Top gainers
Last session